How to Research an OTC Stock: A Step-by-Step Guide

What you need

• The company's profile on the OTC Markets website, which shows the tier, the reporting standard, the transfer agent and any designations.
• The company's filings on EDGAR if it is an SEC reporting company. Our guide on how to search SEC EDGAR filings shows how to pull every 10-K, 10-Q and 8-K.
• If it does not file with the SEC, its annual and quarterly reports from the OTC Disclosure and News Service.
• The FINRA Daily List for symbol changes, name changes and reverse splits.
• A spreadsheet for the share count, with room for convertible notes, warrants and authorized but unissued shares.

The OTC market sorts companies by what they disclose, so the tier tells you where to look and what to expect.

Step 1: Confirm the tier and reporting status

Start with the profile, not the price chart. Note the tier, whether the company is an SEC reporter or posts its reports directly to OTC Markets, and the date of its last annual report.

Under Rule 15c2-11 as amended in 2020, with compliance from September 2021, a broker-dealer generally may not publish a quote for a security unless current information about the issuer is publicly available. That rule is why stale filers fall to the Expert Market, where quotes are hidden. A company that is late on its annual report is one step from losing its public quote, so a missed deadline matters more here than on an exchange. Our explainer on the NT 10-K late filing notice covers what a late filing signals.

Step 2: Read the financial statements and the auditor

Pull the last three annual reports and the latest quarter. Check that the annual statements are audited, who the auditor is and whether the report carries a going concern paragraph. SEC reporting companies must use an auditor registered with the PCAOB; for companies outside SEC reporting, check what the tier requires and what the company actually provides.

Then read the statements the way you would for any small company. The cash flow statement matters most, because many OTC companies lose money and fund themselves through stock sales. If the auditor flags doubt about the company's ability to continue, read our explainer on what a going concern warning means before going further.

Step 3: Rebuild the share count

This is where most OTC research earns its time. Start with shares outstanding from the latest balance sheet, then add every instrument that can become stock:

1. Convertible notes, with the conversion price or formula. Notes that convert at a discount to a future market price can produce large and repeated dilution.
2. Warrants and options, with strike prices and expiry dates.
3. Preferred stock with conversion or super-voting rights.
4. The gap between authorized and outstanding shares, and any recent increase in authorized shares.

Compare the result with the share count the transfer agent reports, if the profile shows it. A large gap, or a fast-rising count, is the most common way OTC holders lose value. Our guide to dilution and share count changes explains how to put each instrument into a per-share figure.

Step 4: Screen for red flags

Check each of these before spending time on valuation:

• Caveat Emptor designation. OTC Markets applies it when it sees a public interest concern, such as promotion, a suspension or a change of control without disclosure.
• SEC trading suspensions. The SEC can suspend trading in a security for up to 10 trading days. Search the company name on sec.gov.
• Shell status. A company that reports itself as a shell, or has nominal operations and assets, faces restrictions on resales of its shares under Rule 144.
• Corporate action history. The FINRA Daily List shows name changes, symbol changes and reverse splits. Several within a few years usually means repeated dilution. Our explainer on reverse stock splits covers the pattern.
• Promotion. Paid newsletters, sudden volume spikes and press releases without filings are a reason to stop.

Step 5: Value the business and check liquidity

If the stock passes the first four steps, value it the way the situation calls for. For an asset play, use net cash and liquidation value on the rebuilt share count. For a foreign company, compare the OTC price with the home market price after currency and the ADR ratio. For an operating business, use the same earnings and cash flow work you would use on a listed company.

Then price the trading cost. Note the average daily dollar volume, the bid-ask spread and how many market makers quote it. A position that takes weeks to build or exit adds risk the valuation does not show. A stock 40% below your estimate of value but with a 6% spread and $20,000 of daily volume offers less than the gap suggests.

Step 6: Name the catalyst and write it down

A cheap OTC stock can stay cheap for years, so the last step is the reason the gap should close and the date it might. Common catalysts include:

• An uplisting to Nasdaq or the NYSE once the company meets the listing standards.
• A return to current reporting, which can move a stock from Pink Limited or the Expert Market back to a higher tier with public quotes.
• A tender offer, buyback or liquidating distribution that returns cash to holders.
• A merger, sale of the company or sale of a major asset.
• A resolved legal or regulatory matter that has kept buyers away.

Write the thesis with the catalyst, its expected date, the per-share value and the evidence that would prove you wrong. Our guide on how to write a dated investment thesis gives a format.

Common mistakes

• Treating the tier as a quality rating. OTCQX tells you the company discloses and meets standards; it does not tell you the stock is cheap or the business is sound.
• Using shares outstanding from the cover page alone. Convertible notes and authorized shares can double the count within a year.
• Ignoring the reporting calendar. A missed annual report can move a stock to the Expert Market and strand holders.
• Valuing at the last trade. In a thin stock the last trade can be far from where size will clear.
• Reading press releases instead of filings. OTC promotions run on releases; the numbers that matter are in the audited statements.

Where this goes wrong

The method depends on the disclosure being accurate, and for some OTC companies it is not. Audits of very small companies vary in quality, related-party dealings are common and controlling holders can act against minority interests with few constraints. A company can also stop reporting, deregister and leave holders with no information and no public quote. Position sizes should reflect that a total loss is a real outcome on many OTC names. For sources that cover special situations on and off the exchanges, see our list of the best investing newsletters for special situations.

The bottom line

Researching an OTC stock is mostly a process of elimination: tier and reporting status, audited statements, a rebuilt share count and a red-flag check remove most candidates before valuation begins. For the few that pass, value them on the fully diluted share count, include the cost of a thin and wide market and name a dated catalyst. Without that catalyst, a cheap OTC stock is usually cheap for a reason that is still in force.